Medical devices, healthcare technology and the business of care
510(k) clearance · K262941

Bausch + Lomb Multifocal for Astigmatism (kalifilcon A) One-Day Soft (hydrophilic) Contact Lens

Bausch + Lomb, Inc. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONK262941

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-16 for K262941, a traditional 510(k) from Bausch + Lomb, Inc. of Rochester, New York, received 08/21/2026. The device is the Bausch + Lomb Multifocal for Astigmatism (kalifilcon A) One-Day Soft (hydrophilic) Contact Lens, classified under regulation 886.5925 as Lenses, Soft Contact, Daily Wear, product code LPL, with subsequent product code MVN and the Ophthalmic review panel. SESE means clearance to market, not PMA approval.

The available FDA PDF excerpt states the lens is indicated for the daily wear correction of, but the excerpt ends there, so the full indication wording is not established here. The excerpt also notes review of the 510(k) against legally marketed predicate devices without naming them. The page lists no third-party review, no combination product status and no authorized predetermined change control plan. Clinical data, labeling details and the predicate identity remain unknown from these excerpts.

The page was last updated 10/26/2026. No supplement type or reason is recorded for this record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Ophthalmic
Decision date
Oct 16, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262941
Regulatory pathway
510(k) premarket notification
Product code
LPL
Decision code
SESE
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Lenses, Soft Contact, Daily Wear.

Product code
LPL
FDA device class
2

FDA decision timeline

  1. K262941 received

    Application receipt date recorded by FDA.

  2. K262941 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LPL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bausch + Lomb, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Rochester, NY

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records